• Lucid fell to a new low after weak revenue guidance, a $300 million stock offering, and multiple analyst price target cuts.
• Beyond Air hit a fresh low after receiving a Nasdaq warning over its sub-$1 share price.
• Conagra Brands slid after naming a new CEO, with analysts warning several macroeconomic factors could keep earnings under pressure.

Shares of Lucid Group, Beyond Air, and Conagra Brands each hit fresh 52-week intraday lows on Wednesday, driven by distinct catalysts. XAIR continued its slide in overnight trading, while LCID and CAG managed to pare some of their regular session losses.

Why LCID Hit A 52-Week Low

Lucid has been in the headlines all week: naming a new CEO, securing fresh funding from Saudi Arabia's sovereign wealth fund, and inking a robotaxi partnership with Uber. But investor sentiment has soured on the back of a significantly weaker-than-expected revenue outlook for the current quarter and a $300 million stock offering. The EV maker has yet to turn a profit, nearly 19 years after its founding.

Wednesday brought a fresh round of price target cuts. Baird lowered its target to $12 from $14, maintaining a 'Neutral' rating, citing the new CEO appointment and the Uber partnership as reasons to update its model. TD Cowen analyst Itay Michaeli cut his target more sharply, to $10 from $19, while keeping a 'Hold' rating.

Despite the pressure, Stocktwits sentiment for LCID was 'extremely bullish' at the last close, suggesting retail traders are betting on a near-term turnaround following the leadership shakeup. The stock hit an intraday 52-week low of $8.11 on Wednesday and is down over 25% year-to-date.

Why XAIR Hit A 52-Week Low

Beyond Air disclosed on Wednesday that it had received a Nasdaq notice for non-compliance with the $1.00 minimum bid price requirement and has requested a hearing before the Nasdaq Hearings Panel, scheduled for May 14, 2026. Any delisting or suspension is stayed pending the panel's written decision, meaning shares are expected to remain listed until the panel issues its decision. However, there is no assurance that the panel will grant continued listing or that compliance will be regained.

The Nasdaq notice compounds a difficult stretch for the medical device and biopharmaceutical company. Last month, CEO Steve Lisi resigned, effective March 27, and the board appointed chief commercial officer Robert Goodman as his replacement. Earlier in March, the company also confirmed that its proposed transaction with XTL Biopharmaceuticals involving Beyond Air's NeuroNOS subsidiary had been terminated after the parties failed to reach a definitive agreement.

On Stocktwits, sentiment for XAIR was 'bullish' at the last close, with several retail traders predicting the stock will avoid delisting. XAIR hit an intraday 52-week low of $0.43 on Wednesday and has shed 28% year to date.

Why CAG Hit A 52-Week Low

Conagra shares have been sliding since Monday, when the packaged food giant named a new CEO, less than a month after cutting its annual profit forecast amid mounting uncertainty around global trade. The market's initial read on the leadership change has not been encouraging.

JPMorgan analysts described the incoming CEO as well-regarded and knowledgeable, but they still expect earnings pressure to build over the coming quarters as Conagra continues to wrestle with inflationary headwinds in freight and packaging. Jefferies echoed that view, noting that the new CEO's near-term options are limited given the company's high leverage, margin pressures, and exposure to inflation.

Retail traders on Stocktwits were 'bullish' on CAG at the last close, with sentiment partly lifted by news that two directors purchased over $700,000 in shares. The stock hit an intraday 52-week low of $14.04 on Wednesday and has shed nearly 19% year-to-date.

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Read Next: Dow, S&P 500, Nasdaq Futures Rise After Trump Says US-Iran War ‘Very Close To Over